Hamidah, M., Widyawaruyanti, A., Widjiati, W. and Prasetyo, B. (2018) “Sambiloto (AS201-01) is better than standard antimalarial drug (DHP) in reducing Toll-Like Receptor 2 (TLR2) on placenta malaria model”, Majalah Obstetri & Ginekologi, 26(2), pp. 74–82. doi: 10.20473/mog.V26I22018.74-82.